Global Markets and Technologies for Advanced Drug Delivery Systems
Global Markets and Technologies for Advanced Drug Delivery Systems
Abstract
Report Scope:
This report aims to provide a comprehensive study of the global market for advance drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions regarding drug deliveries.
An in-depth analysis of the global ADDS market includes historical data and market projections on sales by product type, application, route of administration, drug mechanism and region. The analysis describes the different types of ADDS products (immediate drug release technology, modified drug release, advanced extended release drug delivery devices, and advanced delayed release and pulsatile release drug delivery systems) and their current and historical market revenues. This report also examines applications of ADDS (oncology, respiratory, inflammation and allergies, cardiovascular, ophthalmic, central nervous systems, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal, dermatology and other therapeutics). This ADDS report also covers the route of administration of a drug delivery system as well as the source of a carrier mechanism for drug delivery.
The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.
Report Includes:
- 61 data tables and 61 additional tables
- An up-to-date review and comprehensive analysis of the global markets for advanced drug delivery systems (ADDS) and processes
- Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current state of the advanced drug delivery market, recent technologies and platforms, and market participants
- Estimation of the actual market size and market forecast for advanced drug delivery systems in value terms, and their corresponding market share analysis by technology, application, route of administration, vehicle/carrier of drugs mechanism, and geographic region
- Assessment of major growth drivers, opportunities and challenges in this innovation driven market, with an update on the COVID-19 impact on advanced drug delivery systems
- Review of patents and patent applications filed on drug delivery release mechanisms, clinical trial landscape, and emerging developments in the global market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the advanced drug-device combination products manufacturers, including 3M Co., Abbott Laboratories, B. Braun Melsungen AG, BD, Boston Scientific Corp., Medtronic, Sanofi S.A., and Terumo Corp.
Content
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Scope of Report
1.3 Reasons for Doing This Study
1.4 What's New in This Update?
1.5 Information Sources and Methodology
1.1.1 Secondary Research
1.1.2 Primary Research
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Evaluation of the Market Based on Technology
3.1 Overview of Advanced Drug Delivery Systems and Technologies
3.1.1 Immediate Drug Release Technology
3.1.2 Modified Drug Delivery Segment
3.2 Summary of Market for Advanced Drug Delivery Systems Based on Drug Release Mechanism
Chapter 4 Evaluation of the Market Based on Route of Administration
4.1 Overview of Advanced Drug Delivery Systems and Route of Administration
4.1.1 Oral Drug Delivery System Segment
4.1.2 Parenteral/Injectable Drug Delivery System Segment
4.1.3 Topical Drug Delivery System Segment
4.1.4 Transdermal Drug Delivery System Segment
4.1.5 Transmucosal Drug Delivery System Segment
4.1.6 Nasal and Pulmonary Drug Delivery System Segment
4.1.7 Ocular Drug Delivery System Segment
4.1.8 Oral-Buccal Drug Delivery Segment
4.1.9 Vaginal Drug Delivery Segment
4.1.10 Rectal Drug Delivery Segment
4.1.11 Transmucosal Drug Delivery System Segment
4.1.12 Implant Drug Delivery System Segment
4.1.13 Contraceptive Drug Delivery Device Segment
4.2 Summary of the Market for Advanced Drug Delivery Systems Based on Route of Administration
Chapter 5 Evaluation of the Market Based on Vehicle/Carrier
5.1 Overview of Advanced Drug Delivery Systems and Vehicles/Carriers
5.1.1 Liposomes as Drug Delivery Vehicles
5.1.1 Polymeric Therapeutics in Drug Delivery
5.1.2 Polymeric Micelles (Micelles) in Drug Delivery
5.1.3 Dendrimers in Drug Delivery
5.1.4 Polymers (Polymeric) in Drug Delivery
5.1.5 Nanocarriers/Nanoparticles in Drug Delivery
5.1.6 Microparticles/Microspheres in Drug Delivery
5.1.7 Monoclonal Antibodies (mAbs)
5.1.8 Prodrugs
5.1.9 Other Drug Carriers
5.2 Summary of the Market for Advanced Drug Delivery Systems Based on Drug Delivery Vehicle/Carrier
Chapter 6 Evaluation of the Market Based on Application
6.1 Overview of Advanced Drug Delivery Systems and Applications
6.2 Applications
6.2.1 Cardiovascular
6.2.2 Oncology
6.2.3 Gastrointestinal (GI) Disorders
6.2.4 Urology
6.2.5 Diabetes
6.2.6 Dermatology
6.2.7 Central Nervous System
6.2.8 Respiratory
6.2.9 Inflammatory Diseases and Allergies
6.2.10 Ophthalmology
6.2.11 Viral and Bacterial Diseases
6.2.12 Hormone Replacement Therapy and Gynecology
6.2.13 Other Therapeutic Applications
6.3 Summary of the Market for Advanced Drug Delivery Systems Based on Application
Chapter 7 Evaluation of the Market Based on Geographic Region
7.1 Overview of the Geographical Distribution of the Market for Advanced Drug Delivery Systems
7.1.1 North America
7.1.2 Europe
7.1.3 Asia-Pacific
7.1.4 Rest of the World (ROW)
7.2 Summary of the Market for Advanced Drug Delivery Systems Based on Region
Chapter 8 COVID-19 Impact on the Market
8.1 Overview
8.2 Impact on Advance Drug Delivery Systems
8.3 COVID-19 Drugs
8.4 Types of Authorized Products
8.5 Antiviral Drugs
8.6 Immune Modulators
8.7 Sedatives
8.8 Renal Replacement Therapies
Chapter 9 Patents/Clinical Trials on Advanced Drug Delivery Systems
9.1 Trends in Clinical Trials on Drug Delivery Systems
Chapter 10 Market Dynamics
10.1 Overview
10.2 Market Drivers and Restraints
Chapter 11 Company Profiles
3M
ABBOTT LABORATORIES
ABBVIE, INC.
B. BRAUN MELSUNGEN AG
BD
BOSTON SCIENTIFIC CORP.
COSMED PHARMACEUTICAL CO., LTD.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC INC.
SANOFI S.A.
SMITH & NEPHEW PLC
STRYKER CORP.
TERUMO CORP.
Report Scope:
This report aims to provide a comprehensive study of the global market for advance drug delivery systems (ADDS) and processes, both in terms of quantitative and qualitative data, to help people and companies develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace and make informed business decisions regarding drug deliveries.
An in-depth analysis of the global ADDS market includes historical data and market projections on sales by product type, application, route of administration, drug mechanism and region. The analysis describes the different types of ADDS products (immediate drug release technology, modified drug release, advanced extended release drug delivery devices, and advanced delayed release and pulsatile release drug delivery systems) and their current and historical market revenues. This report also examines applications of ADDS (oncology, respiratory, inflammation and allergies, cardiovascular, ophthalmic, central nervous systems, hormone replacement therapy and gynecology, viral and bacterial diseases, diabetes, urology, gastrointestinal, dermatology and other therapeutics). This ADDS report also covers the route of administration of a drug delivery system as well as the source of a carrier mechanism for drug delivery.
The geographic scope of this study covers the U.S. and companies worldwide. The report identifies the main elements of advanced drug delivery products and trends in different industries.
Report Includes:
- 61 data tables and 61 additional tables
- An up-to-date review and comprehensive analysis of the global markets for advanced drug delivery systems (ADDS) and processes
- Analyses of the global market trends, with historic market revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current state of the advanced drug delivery market, recent technologies and platforms, and market participants
- Estimation of the actual market size and market forecast for advanced drug delivery systems in value terms, and their corresponding market share analysis by technology, application, route of administration, vehicle/carrier of drugs mechanism, and geographic region
- Assessment of major growth drivers, opportunities and challenges in this innovation driven market, with an update on the COVID-19 impact on advanced drug delivery systems
- Review of patents and patent applications filed on drug delivery release mechanisms, clinical trial landscape, and emerging developments in the global market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the advanced drug-device combination products manufacturers, including 3M Co., Abbott Laboratories, B. Braun Melsungen AG, BD, Boston Scientific Corp., Medtronic, Sanofi S.A., and Terumo Corp.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Scope of Report
1.3 Reasons for Doing This Study
1.4 What's New in This Update?
1.5 Information Sources and Methodology
1.1.1 Secondary Research
1.1.2 Primary Research
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Evaluation of the Market Based on Technology
3.1 Overview of Advanced Drug Delivery Systems and Technologies
3.1.1 Immediate Drug Release Technology
3.1.2 Modified Drug Delivery Segment
3.2 Summary of Market for Advanced Drug Delivery Systems Based on Drug Release Mechanism
Chapter 4 Evaluation of the Market Based on Route of Administration
4.1 Overview of Advanced Drug Delivery Systems and Route of Administration
4.1.1 Oral Drug Delivery System Segment
4.1.2 Parenteral/Injectable Drug Delivery System Segment
4.1.3 Topical Drug Delivery System Segment
4.1.4 Transdermal Drug Delivery System Segment
4.1.5 Transmucosal Drug Delivery System Segment
4.1.6 Nasal and Pulmonary Drug Delivery System Segment
4.1.7 Ocular Drug Delivery System Segment
4.1.8 Oral-Buccal Drug Delivery Segment
4.1.9 Vaginal Drug Delivery Segment
4.1.10 Rectal Drug Delivery Segment
4.1.11 Transmucosal Drug Delivery System Segment
4.1.12 Implant Drug Delivery System Segment
4.1.13 Contraceptive Drug Delivery Device Segment
4.2 Summary of the Market for Advanced Drug Delivery Systems Based on Route of Administration
Chapter 5 Evaluation of the Market Based on Vehicle/Carrier
5.1 Overview of Advanced Drug Delivery Systems and Vehicles/Carriers
5.1.1 Liposomes as Drug Delivery Vehicles
5.1.1 Polymeric Therapeutics in Drug Delivery
5.1.2 Polymeric Micelles (Micelles) in Drug Delivery
5.1.3 Dendrimers in Drug Delivery
5.1.4 Polymers (Polymeric) in Drug Delivery
5.1.5 Nanocarriers/Nanoparticles in Drug Delivery
5.1.6 Microparticles/Microspheres in Drug Delivery
5.1.7 Monoclonal Antibodies (mAbs)
5.1.8 Prodrugs
5.1.9 Other Drug Carriers
5.2 Summary of the Market for Advanced Drug Delivery Systems Based on Drug Delivery Vehicle/Carrier
Chapter 6 Evaluation of the Market Based on Application
6.1 Overview of Advanced Drug Delivery Systems and Applications
6.2 Applications
6.2.1 Cardiovascular
6.2.2 Oncology
6.2.3 Gastrointestinal (GI) Disorders
6.2.4 Urology
6.2.5 Diabetes
6.2.6 Dermatology
6.2.7 Central Nervous System
6.2.8 Respiratory
6.2.9 Inflammatory Diseases and Allergies
6.2.10 Ophthalmology
6.2.11 Viral and Bacterial Diseases
6.2.12 Hormone Replacement Therapy and Gynecology
6.2.13 Other Therapeutic Applications
6.3 Summary of the Market for Advanced Drug Delivery Systems Based on Application
Chapter 7 Evaluation of the Market Based on Geographic Region
7.1 Overview of the Geographical Distribution of the Market for Advanced Drug Delivery Systems
7.1.1 North America
7.1.2 Europe
7.1.3 Asia-Pacific
7.1.4 Rest of the World (ROW)
7.2 Summary of the Market for Advanced Drug Delivery Systems Based on Region
Chapter 8 COVID-19 Impact on the Market
8.1 Overview
8.2 Impact on Advance Drug Delivery Systems
8.3 COVID-19 Drugs
8.4 Types of Authorized Products
8.5 Antiviral Drugs
8.6 Immune Modulators
8.7 Sedatives
8.8 Renal Replacement Therapies
Chapter 9 Patents/Clinical Trials on Advanced Drug Delivery Systems
9.1 Trends in Clinical Trials on Drug Delivery Systems
Chapter 10 Market Dynamics
10.1 Overview
10.2 Market Drivers and Restraints
Chapter 11 Company Profiles
3M
ABBOTT LABORATORIES
ABBVIE, INC.
B. BRAUN MELSUNGEN AG
BD
BOSTON SCIENTIFIC CORP.
COSMED PHARMACEUTICAL CO., LTD.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC INC.
SANOFI S.A.
SMITH & NEPHEW PLC
STRYKER CORP.
TERUMO CORP.
Related Report
